NEXGEL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
NEXGEL, INC. (NXGL) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 11.98 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-17
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 125.00K shares, a 70.37% decline year-over-year.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-12-31 was 421.82K shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-09-30 was 255.36K shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-06-30 was 0.00 shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 387.39K shares, a 59.13% decline from fiscal 2024.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 947.79K shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2021 was 3.43B shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 11.98M shares 10-Q · filed 2026-08-17 | |||
| 2025-12-31 | 125.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 387.39K shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 262.39K shares 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | 421.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 677.18K shares derived: sum of 2 quarters · filed 2026-03-31 | 677.18K shares derived: sum of 3 quarters · filed 2026-03-31 | 947.79K shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 255.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 255.36K shares derived: sum of 2 quarters · filed 2024-11-13 | 525.97K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 270.62K shares 10-Q · filed 2024-08-19 | ||
| 2024-03-31 | 270.62K shares 10-Q · filed 2024-05-13 | |||
| 2021-12-31 | 3.43B shares 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |